How to buy Vaxart shares | $6.08

Vaxart, Inc is a biotechnology business with stocks listed in the US. Vaxart shares (VXRT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$6.08 – the same closing value as a week prior.

How to buy shares in Vaxart

1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
3. Search for Vaxart. Find the share by name or ticker symbol: VXRT. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Vaxart reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of US$6.08, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Vaxart, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Vaxart. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Vaxart's share price?

Since the stock market crash in March caused by coronavirus, Vaxart's share price has had significant positive movement.

Its last market close was US$6.08, which is 82.07% up on its pre-crash value of US$1.09 and 525.64% up on the lowest point reached during the March crash when the shares fell as low as US$0.9718.

If you had bought US$1,000 worth of Vaxart shares at the start of February 2020, those shares would have been worth US$1,156.25 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth US$3,800.00.

Vaxart share price

Use our graph to track the performance of VXRT stocks over time.

Vaxart shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	USD$6.08
52-week range	USD$0.266 - USD$17.49
50-day moving average	USD$6.6543
200-day moving average	USD$6.0597
Target price	USD$19.67
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-2.033

Get $0 brokerage on US stocks with trades as little as $50 when you join the world’s biggest social trading network.

eToro Share Trading (US stocks)

USD 0

Standard brokerage - US shares

Get $0 brokerage on US stocks with trades as little as $50 when you join the world’s biggest social trading network.

• $0 brokerage for US stocks
• Trades starting from $50
• Fractional shares
• Copy top traders

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Vaxart stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Vaxart, Inc by TradingView

Vaxart price performance over time

Historical closes compared with the close of $6.08 on 2020-10-16

1 week (2020-10-22)	11.56%
1 month (2020-09-29)	-10.98%
3 months (2020-07-29)	-39.32%
6 months (2020-04-29)	102.67%

1 year (2019-10-29)	1,861.29%
2 years (2018-10-29)	121.09%
3 years (2017-10-27)	632.62%
5 years (2015-10-29)	205.53%

Vaxart financials

Revenue TTM	US$7.8 million
Gross profit TTM	US$-4,678,000
Return on assets TTM	-17.91%
Return on equity TTM	-78.26%
Profit margin	-281.5%
Book value	0.419
Market capitalisation	US$595.5 million

TTM: trailing 12 months

Shorting Vaxart shares

There are currently 24.8 million Vaxart shares held short by investors – that's known as Vaxart's "short interest". This figure is 42.1% up from 17.4 million last month.

There are a few different ways that this level of interest in shorting Vaxart shares can be evaluated.

Vaxart's "short interest ratio" (SIR)

Vaxart's "short interest ratio" (SIR) is the quantity of Vaxart shares currently shorted divided by the average quantity of Vaxart shares traded daily (recently around 31.0 million). Vaxart's SIR currently stands at 0.8. In other words for every 100,000 Vaxart shares traded daily on the market, roughly 800 shares are currently held short.

However Vaxart's short interest can also be evaluated against the total number of Vaxart shares, or, against the total number of tradable Vaxart shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vaxart's short interest could be expressed as 0.23% of the outstanding shares (for every 100,000 Vaxart shares in existence, roughly 230 shares are currently held short) or 0.2975% of the tradable shares (for every 100,000 tradable Vaxart shares, roughly 298 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Vaxart.

Find out more about how you can short Vaxart stock.

Vaxart share dividends

We're not expecting Vaxart to pay a dividend over the next 12 months.

Have Vaxart's shares ever split?

Vaxart's shares were split on a 1:11 basis on 13 February 2018. So if you had owned 11 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vaxart shares – just the quantity. However, indirectly, the new 1000% higher share price could have impacted the market appetite for Vaxart shares which in turn could have impacted Vaxart's share price.

Vaxart share price volatility

Over the last 12 months, Vaxart's shares have ranged in value from as little as US$0.266 up to US$17.49. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vaxart's is -0.0347. This would suggest that Vaxart's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Vaxart has bucked the trend.

Vaxart overview

Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines for cervical cancer and dysplasia caused by human papillomavirus. Vaxart, Inc. has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. The company is headquartered in South San Francisco, California.

Frequently asked questions

• What percentage of Vaxart is owned by insiders or institutions?

  Currently 1.209% of Vaxart shares are held by insiders and 36.233% by institutions.

• When does the fiscal year end for Vaxart?

  Vaxart's fiscal year ends in December.

• Where is Vaxart based?

  Vaxart's address is: 395 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

• What is Vaxart's ISIN number?

  Vaxart's international securities identification number is: US92243A2006

• What is Vaxart's CUSIP number?

  Vaxart's Committee on Uniform Securities Identification Procedures number is: 053761102